DelistingJun 12, 2026, 08:01 AM
BioCardia Regains Nasdaq Compliance with $4.9M Share Sale
AI Summary
BioCardia, Inc. announced it has regained compliance with Nasdaq's minimum $2.5 million stockholders' equity requirement. The company previously received a delisting notice and was granted an extension until October 7, 2026, to comply. Through an "At The Market" offering, BioCardia sold 4,004,330 shares between April 1 and June 5, 2026, generating $4.9 million in net proceeds, which it believes has restored its stockholders' equity above the threshold.
Key Highlights
- BioCardia regained compliance with Nasdaq's $2.5 million stockholders' equity rule.
- The company previously received a delisting notice on April 10, 2026.
- Nasdaq granted an extension until October 7, 2026, to regain compliance.
- Sold 3,509,604 shares at an average price of $1.279 on June 5, 2026.
- Total 4,004,330 shares sold from April 1 to June 5, 2026.
- Generated $4.9 million in net proceeds from the share sales.
- Stockholders' equity now exceeds $2.5 million.
Price Impact
More from BCDA